Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capecitabine and Radiation in Pediatric Brainstem Gliomas
NCT01118377Phase 2Completed
- Sponsor
- Roche
- Start
- May 2007
- Primary completion
- Jan 2013
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of capecitabine in brainstem glioma, sponsored by Roche. Started May 2007; status: completed.
02
Drugs
capecitabine
03
Conditions
brainstem glioma
Beyond the preview
Go deeper on NCT01118377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01118377.